Spectranetics Corp.
Colorado Springs, Colo.-based Spectranetics Corp., a single-use
medical device manufacturer, has announced its clinical trial plans related to the
treatment of in-stent restenosis in arteries above the knee. Currently, there are
no devices cleared or approved by the FDA to treat in-stent restenosis. The company
has planned to initiate a multicenter randomized trial in the US to compare laser
ablation followed by adjunctive balloon angioplasty with balloon angioplasty alone.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024